The Journal of Organic Chemistry
Article
1H), 7.13 (d, J = 8.7 Hz, 2H), 8.14 (d, J = 8.7 Hz, 2H). 13C NMR (100
MHz, CDCl3): δ 31.7 (q), 49.8 (t), 96.7 (d), 123.7 (d), 124.6 (d),
142.8 (s), 147.3(s), 150.6 (s), 152.8 (s). MS (%) ESI: 268 [M + H]+.
Anal. Calcd for C11H10ClN3O3: C, 49.36; H, 3.77; N, 15.70. Found: C,
49.59; H, 3.54; N, 15.85.
NMR (100 MHz, CDCl3): δ 31.8 (q), 49.9 (t), 95.7 (d), 117.9 (d),
122.7 (d), 124.1 (d), 125.1 (d), 125.9 (d), 127.8 (d), 129.3 (s), 134.3
(s), 142.7 (s), 148.0 (s), 149.6 (s). MS (%) ESI: 273 [M + H]+. Anal.
Calcd for C15H13ClN2O: C, 66.06; H, 4.80; N, 10.27. Found: C, 65.87;
H, 5.11; N, 10.51.
(E)-2-[3,5-Bis(trifluoromethyl)phenylimino]-5-(chloromethyli-
dene)-3-methyloxazolidine (2f). Colorless oil (268 mg, 75%). Eluent:
petroleum ether/AcOEt 6/4. νmax/cm−1: 1668 (CN). 1H NMR
(400 MHz, CDCl3): δ 3.10 (s, 3H), 4.30 (d, J = 2.8 Hz, 2H), 5.99 (t, J
= 2.8 Hz, 1H), 7.50 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 31.9
(q), 50.2 (t), 97.9 (d), 116.6 (d), 123.3 (q, J = 271.3, Hz), 123.9 (d),
131.9 (q, J = 33.2 Hz), 145.9 (s), 147.0 (s), 151.7 (s). MS (%) ESI:
359 [M + H]+. Anal. Calcd for C13H9ClF6N2O: C,43.53; H, 2.53; N,
7.81. Found: C,43.76; H, 2.29; N, 7.99.
(E)-3-Benzyl-5-(chloromethylidene)-2-(phenylimino)oxazolidine
(2g). Colorless oil (292 mg, 98%). Eluent: petroleum ether/AcOEt 7/
3. νmax/cm−1: 1632 (CN). 1H NMR (400 MHz, CDCl3): δ 4.12 (d,
J = 2.9 MHz, 2H), 4.74 (br s, 2H), 5.91 (t, J = 2.9 Hz, 1H), 7.06−7.11
(m, 3H), 7.27−7.44 (m, 7H). 13C NMR (100 MHz, CDCl3): δ 47.2
(t), 48.8 (t), 96.3 (d), 119.9 (d), 123.3 (d), 123.7 (d), 128.1 (d), 128.4
(d), 128.9 (d), 145.3 (s), 148.1 (s), 149.9 (s), 171.1 (s). MS (%) ESI:
299 [M + H]+. Anal. Calcd for C17H15ClN2O: C, 68.34; H, 5.06; N,
9.38. Found: C, 68.58; H, 5.17; N, 9.21.
(E)-5-(Bromomethylidene)-3-methyl-2-[(4-nitrophenyl)imino]-
oxazolidine (3a). White solid (292 mg, 94%). Eluent: petroleum
1
ether/AcOEt 3/2. Mp: 210−211 °C. νmax/cm−1: 1658 (CN). H
NMR (400 MHz, CDCl3): δ 3.03 (s, 3H), 4.18 (d, J = 2.8 Hz, 2H),
5.90 (t, J = 2.8 Hz, 1H), 7.07 (d, J = 9.0 Hz, 2H), 8.07 (d, J = 9.0 Hz,
2H). 13C NMR (100 MHz, CDCl3): δ 31.7 (q), 51.1 (t), 83.3 (d),
123.7 (d), 124.6 (d), 142.7 (s), 148.1 (s), 150.4 (s), 153.2 (s). MS (%)
ESI: 312 [M + H]+. Anal. Calcd for C11H10BrN3O3: C, 42.33; H, 3.23;
N, 13.46. Found: C, 42.52; H, 3.47; N, 13.21.
(E)-5-(Bromomethylidene)-2-[(4-chlorophenyl)imino]-3-methyl-
oxazolidine (3d). Colorless oil (285 mg, 95%). Eluent: petroleum
1
ether/AcOEt 3/2. νmax/cm−1: 1653 (CN); H NMR (400 MHz,
CDCl3): δ 3.03 (s, 3H), 4.16 (d, J = 2.7 Hz, 2H), 5.86 (t, J = 2.7 Hz,
1H), 6.97 (d, J = 8.7 Hz, 2H), 7.21 (d, J = 8.7 Hz, 2H). 13C NMR (100
MHz, CDCl3): δ 31.7 (q), 51.1 (t), 82.5 (d), 124.7 (d), 127.6 (s),
128.6 (d), 144.8 (s), 148.5 (s), 149.9 (s). MS: m/z 300 (M+). Anal.
Calcd for C11H10BrClN2O: C, 43.81; H, 3.34; N, 9.29. Found: C,
43.90; H, 3.58; N, 9.55.
(E)-3-Benzyl-6-(bromomethylidene)-2-[(2-methoxyphenyl)-
imino]-2,3,4,5-tetrahydro-2H-1,3-oxazine (3m). Colorless oil (239
mg, 62%). Eluent: petroleum ether/AcOEt 7/3. νmax/cm−1: 1641
(E)-3-Benzyl-5-(chloromethylidene)-2-[(4-nitrophenyl)imino]-
oxazolidine (2h). Colorless oil (243 mg, 71%). Eluent: petroleum
1
ether/AcOEt 6/4. νmax/cm−1: 1590 (CN). H NMR (400 MHz,
1
(CN). H NMR (400 MHz, CDCl3): δ 2.74 (t, J = 5.7 Hz, 2H),
CDCl3): δ 4.16 (d, J = 2.9 Hz, 2H), 4.68 (s, 2H), 5.99 (t, J = 2.9 Hz,
1H), 7.17(d, J = 9.0 Hz, 2H), 7.35−7.44 (m, 5H), 8.15 (d, J = 9.0 Hz,
2H). 13C NMR (100 MHz, CDCl3): δ 47.1 (t), 48.7 (t), 97.0 (d),
123.8 (d), 124.7 (d), 124.9 (d), 125.1 (d), 128.3 (d), 128.6 (d), 135.0
(s), 142.8 (s), 147.5 (s), 150.3 (s), 153.0 (s). MS (%) ESI: 344 [M +
H]+. Anal. Calcd for C17H14ClN3O3: C, 59.40; H, 4.10; N, 12.22.
Found: C, 59.58; H, 3.78; N, 12.31.
3.32 (t, J = 5.7 Hz, 2H), 3.81 (s, 3H), 4.82 (br s, 2H), 5.77 (s, 1H),
6.82−7.08 (m, 3H), 7.30−7.45 (m, 6H). 13C NMR (CDCl3): δ 25.1
(t), 41.9 (t), 53.3 (t), 56.0 (q), 89.1 (d), 114.6 (d), 123.5 (d), 127.8
(d), 128.3 (d), 128.9 (d), 131.9 (s), 136.5 (s), 149.4 (s), 152.7 (s),
162.2 (s). MS (%) ESI: 387 [M + H]+. Anal. Calcd for C19H19BrN2O2:
C.58.93; H, 4.95; N, 7.23. Found: C, 59.19; H, 4.74; N, 7.49.
General Procedure for Catalytic Intramolecular Alkoxyhalo-
genation of Alkynyl Ureas. A solution of alkynyl urea (1 mmol),
CuCl2 (0.05 mmol), and the suitable NXS (1 mmol) in MeCN (14
mL) was heated at reflux for 6 h. The solvent was removed under
reduced pressure, and when required the crude product was purified
by silica gel column chromatography.
(E)-3-Benzyl-5-(chloromethylidene)-2-[(4-chlorophenyl)imino]-
oxazolidine (2i). Colorless oil (282 mg, 85%). Eluent: petroleum
1
ether/AcOEt 6/4. νmax/cm−1: 1669 (CN). H NMR (400 MHz,
CDCl3): δ 4.10 (d, J = 2.8 Hz, 2H), 4.63 (s, 2H), 5.92 (t, J = 2.8 Hz,
1H), 7.03 (d, J = 8.8 Hz, 2H), 7.24 (d, J = 8.8 Hz, 2H), 7.37−7.41 (m,
5H). 13C NMR (100 MHz, CDCl3): δ 47.1 (t), 48.7 (t), 96.1 (d),
124.7 (d), 127.7 (s), 128.8 (d), 128.9 (d), 129.1 (d), 129.2 (d); 135.5
(s). 144.8 (s), 148.0 (s), 149.3 (s). MS (%) ESI: 333 [M + H]+. Anal.
Calcd for C17H14Cl2N2O: C, 61.28; H, 4.23; N, 8.41. Found: C, 61.11;
H, 4.40; N, 8.69.
(E)-5-(Chloromethylidene)-3-methyl-2-(phenylimino)oxazolidine
(2b). Colorless oil (142 mg, 64%). Eluent: petroleum ether/AcOEt 7/
3. νmax/cm−1: 1643 (CN). 1H NMR (400 MHz, CDCl3): δ 3.01 (s,
3H), 4.17 (d, J = 2.8 Hz, 2H), 5.90 (t, J = 2.8 Hz, 1H), 7.03−7.09 (m,
3H), 7.29 (t, J = 7.7 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ31.6 (q),
49.7 (t), 95.7 (d), 122.7 (d), 123.3 (d), 128.6 (d), 146.3 (s), 148.2 (s),
149.5 (s). MS (%) ESI: 223 [M + H]+. Anal. Calcd for C11H11ClN2O:
C, 59.33; H, 4.98; N, 12.58. Found: C, 59.45; H, 5.29; N, 12.28.
(E)-5-(Chloromethylidene)-2-[(4-methoxyphenyl)imino]-3-meth-
yloxazolidine (2c). White solid (207 mg, 82%). Eluent: petroleum
(E)-3-Benzyl-6-(chloromethylidene)-2-(phenylimino)-2,3,4,5-tet-
rahydro-2H-1,3-oxazine (2j). Colorless oil (87 mg, 28%). Eluent:
petroleum ether/AcOEt 7/3. νmax/cm−1: 1641 (CN). 1H NMR
(400 MHz, CDCl3): δ 2.79 (td, J = 6.3, 1.5 Hz, 2H), 3.28 (t, J = 6.3
Hz, 2H), 4.82 (s, 2H), 5.88 (t, J = 1.5 Hz, 1H), 7.01−7.05 (m, 3H),
7.26−7.42 (m, 7H). 13C NMR (100 MHz, CDCl3): δ 23.4 (t), 41.8
(t), 53.3 (t), 101.6 (d), 122.4 (d), 123.6 (d), 127.7 (d), 128.2 (d),
128.4 (d), 128.5 (d), 128.7 (d), 136.7 (s), 140.9 (s), 146.2 (s), 148.9
(s). MS (%) ESI: 313 [M + H]+. Anal. Calcd for C18H17ClN2O: C,
69.12; H, 5.48; N, 8.96. Found: C, 69.31; H, 5.62; N, 8.65.
1
ether/AcOEt 6/4. Mp: 137 °C. νmax/cm−1: 1657 (CN). H NMR
(400 MHz, CDCl3): δ 3.01 (s, 3H), 3.76 (s, 3H), 4.19 (d, J = 2.8 Hz,
2H), 5.89 (t, J = 2.8 Hz, 1H), 6.82 (d, J = 8.0 Hz, 2H), 6.97 (d, J = 8.0
Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 31.8 (q), 49.8 (t), 55.4 (q),
95.5 (d), 113.9 (d), 124.1 (d), 139.2 (s), 148.1 (s), 149.3 (s), 155.3
(s). MS (%) ESI: 253 [M + H]+. Anal. Calcd for C12H13ClN2O2: C,
57.04; H, 5.19; N, 11.09. Found: C, 57.21; H, 4.99; N, 11.37.
(E)-5-(Chloromethylidene)-2-[(4-chlorophenyl)imino]-3-methyl-
oxazolidine (2d). White solid (30 mg, 12%). Eluent: petroleum ether/
(E)-3-Benzyl-6-(chloromethylidene)-2-[(4-nitrophenyl)imino]-
2,3,4,5-tetrahydro-2H-1,3-oxazine (2k). Colorless oil (199 mg, 56%).
1
Eluent: petroleum ether/AcOEt 7/3. νmax/cm−1: 1641 (CN). H
NMR (400 MHz, CDCl3): δ 2.84 (t, J = 6.1 Hz, 2H), 3.36 (t, J = 6.1
Hz, 2H), 4.84 (s, 2H), 5.94 (br s, 1H), 7.11 (d, J = 8.6 Hz, 2H), 7.34−
7.40 (m, 5H), 8.15 (d, J = 8.6 Hz, 2H). 13C NMR (100 MHz, CDCl3):
δ 22.9 (t), 42.0 (t), 53.7 (t), 102.6 (d), 123.9 (d), 124.6 (d), 128.0 (d),
128.1 (d), 128.9 (d), 135.9 (s), 142.5 (s), 145.1 (s), 147.1 (s), 148.3
(s). MS (%) ESI: 358 [M + H]+. Anal. Calcd for C18H16ClN3O3: C,
60.42; H, 4.51; N, 11.74. Found: C, 60.71; H, 4.29; N, 11.95.
1
AcOEt 7/3. Mp: 188 °C. νmax/cm−1: 1661 (CN). H NMR (400
MHz, CDCl3): δ 3.15 (s, 3H), 4.30 (d, J = 2.8 Hz, 2H), 5.97 (t, J = 2.8
Hz, 1H), 7.04 (d, J = 8.7 Hz, 2H), 7.22 (d, J = 8.7 Hz, 2H). 13C NMR
(100 MHz, CDCl3): δ 32.1 (q), 50.3 (t), 97.2 (d), 124.8 (d), 128.8
(d), 142.4 (s), 147.4 (s), 151.2 (s), 167.3 (s). MS (%) ESI: 257 [M +
H]+. Anal. Calcd for C11H10 Cl2N2O: C, 51.38; H, 3.92; N, 10.90.
Found: C, 51.60; H, 3.73; N, 11.15.
(E)-3-Benzyl-6-(chloromethylidene)-2-(naphthylimino)-2,3,4,5-
tetrahydro-2H-1,3-oxazine (2l). Colorless oil (278 mg, 77%). Eluent:
petroleum ether/AcOEt 6/4. νmax/cm−1: 1641 (CN). 1H NMR
(400 MHz, CDCl3): δ 2.81−2.85 (m, 2H), 3.37 (t, J = 6.2 Hz, 2H),
4.91 (s, 2H), 5.73 (s, 1H), 6.97 (d, J = 7.8 Hz, 1H), 7.33−7.58 (m,
9H), 7.95−8.08 (m, 1H), 8.12−8.24 (m, 1H). 13C NMR (100 MHz,
CDCl3): δ 23.3 (t), 42.2 (t), 53.6 (t), 101.6 (d), 113.8 (s), 117.9 (d),
(E)-5-(Chloromethylidene)-3-methyl-2-[(1-naphthyl)imino]-
oxazolidine (2e). Pale yellow oil (266 mg, 98%). Eluent: petroleum
1
ether/AcOEt 7/3. νmax/cm−1: 1668 (CN). H NMR (400 MHz,
CDCl3): δ 3.12 (s, 3H), 4.20 (d, J = 2.7 Hz, 2H), 5.85 (t, J = 2.7 Hz,
1H), 7.18 (d, J = 7.3 Hz, 1H), 7.43−7.51 (m, 3H), 7.59 (d, J = 8.2 Hz,
1H) 7.84 (dd, J = 6.4, 3.3 Hz, 1H), 7.25 (dd, J = 6.4, 3.3 Hz, 1H). 13C
F
J. Org. Chem. XXXX, XXX, XXX−XXX